Ken Fisher acquired 107 Thousand Bio-Rad Laboratories shares worth $25.5 Million. The first Bio-Rad Laboratories trade was made in Q1 2013. Since then Ken Fisher bought shares eleven more times and sold shares on 36 occasions. The stake costed the investor $15.9 Million, netting the investor a gain of 60% so far.
Major players in the stem cell assay market are Thermo Fisher Scientific Inc. , Merck Group, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Labor...
The Urinalysis Market report delivers a holistic analysis to understand the development scope and derive the growth rate for the forecast period. The report ...
Major players in the liquid biopsy market are QIAGEN N. V. , Roche Diagnostics, Bio-Rad Laboratories Inc. , Myriad Genetics, Inc. , Guardant Health Inc. , Th...
Major players in the protein labeling market are Thermo Fisher Scientific Inc, Merck KGaA, PerkinElmer, Inc. , General Electric Company, F. Hoffmann-La Roche...